We have developed a novel class of specifically engineered, dimerized cyclodextrin (CD) nanostructures for the encapsulation of toxic biomolecules such as 7-ketocholesterol (7KC). 7KC accumulates over time and causes dysfunction in many cell types, linking it to several age-related diseases
AR,VR&3D-printing
Virtual Reality, Augmented Reality & 3D-printing solutions
…for dissemination and research in Chemistry and Biology
Software development
Software development
…to simulate and analyse the structural and dynamic behaviour of molecules and molecular aggregates
About us
MD.USE is a USC spin-off founded in July 2015 by a team led by group of senior researchers with broad experience in computational simulation of a large variety of molecular systems. The company is composed now by an interdisciplinary team,...
Read moreRemdesivir interactions with sulphobutylether-β-cyclodextrins: A case study using selected substitution patterns
Abstract Modified cyclodextrins (CDs) consist of a distribution of different structures with different number and location of the substituted groups. Among the most important applications of these molecules is their use as an enabling excipient in pharmaceutical formulations to provide
Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir
The formation of small hybrid aggregates between excipient and drug molecules is one of the mechanisms that contributes to the solubilization of active principles in pharmaceutical formulations. The characterization of the formation, governing interactions and structure of such entities is
Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition
Underdog Pharmaceuticals, Inc., a pharmaceutical company designing engineered cyclodextrins to address atherosclerosis and other serious diseases of aging, has completed a partnership and technology acquisition agreement with MD.USE Innovative Solutions, SL. Read more